Search for: "Bristol-Myers Squibb Company"
Results 121 - 140
of 465
Sort by Relevance
|
Sort by Date
29 Jun 2017, 2:29 pm
Seyfarth Synopsis: In Bristol-Myers Squibb Company v. [read post]
29 Jun 2017, 11:06 am
In Bristol-Myers Squibb Co. v. [read post]
29 Jun 2017, 11:06 am
In Bristol-Myers Squibb Co. v. [read post]
28 Jun 2017, 8:34 am
Ability’s manufacturers, Otsuka and Bristol-Myers Squibb, are facing a growing number of lawsuits from patients who claim they couldn’t control the urge to gamble or over-eat, or that they developed hyper sexual behaviors. [read post]
27 Jun 2017, 8:00 am
On June 19, 2017, the Supreme Court reinforced its narrow application of specific jurisdiction in mass tort proceedings in an 8-1 decision in Bristol-Myers Squibb Company v. [read post]
27 Jun 2017, 8:00 am
On June 19, 2017, the Supreme Court reinforced its narrow application of specific jurisdiction in mass tort proceedings in an 8-1 decision in Bristol-Myers Squibb Company v. [read post]
26 Jun 2017, 3:34 am
And tune in for our October 10 webcast – “E&S Disclosures: The In-House Perspective” – featuring experts from the Coca-Cola Company, Bristol-Myers Squibb, Apple & Clorox. [read post]
22 Jun 2017, 11:23 am
Bristol-Myers Squibb (“BMS”) objected to the exercise of personal jurisdiction over it with respect to the nonresident plaintiffs’ claims. [read post]
22 Jun 2017, 11:23 am
Bristol-Myers Squibb (“BMS”) objected to the exercise of personal jurisdiction over it with respect to the nonresident plaintiffs’ claims. [read post]
20 Jun 2017, 1:15 pm
Bristol-Myers Squibb Company v. [read post]
20 Jun 2017, 4:29 am
And in Bristol-Myers Squibb Co. v. [read post]
19 Jun 2017, 11:56 am
The court’s decision this morning in Bristol-Myers Squibb v. [read post]
24 May 2017, 7:38 am
” Bristol-Myers Squibb and Otsuka began marketing the drug in the US in 2002. [read post]
16 May 2017, 9:40 am
Otsuka and Bristol-Myers Squibb promoted Abilify for unapproved uses. [read post]
29 Apr 2017, 10:08 am
Wrendell Chester, from Texas, recently filed a personal injury and product liability lawsuit, against Bristol-Myers Squibb and AstraZeneca, the manufacturers of the drug. [read post]
12 Apr 2017, 2:22 pm
An Observational Study Compared Myocardial Infarction / Heart Attack Risks As Between The Use Of Newer Blood Thinners And The Use Of Warfarin (Posted by Tom Lamb at DrugInjuryWatch.com) In the US, there are currently four direct-acting oral anticoagulants (DOACs), a relatively new class of blood thinners, approved for the prevention of stroke in patients with atrial fibrillation (AF): Pradaxa (dabigatran) -- approved by FDA in 2010 -- Boehringer Ingelheim Pharmaceuticals Xarelto… [read post]
8 Mar 2017, 12:37 pm
Further, Defendant Bristol-Myers Squibb has its principal place of business in New York.... [read post]
23 Feb 2017, 7:21 am
As of December 2016, approximately 34 Eliquis lawsuits were pending against the drug’s manufacturers, Bristol-Myers Squibb and Pfizer, Inc. [read post]
17 Feb 2017, 12:21 pm
Bristol-Myers Squibb Co. v. [read post]
14 Feb 2017, 8:05 am
For this reason, sales of Eliquis, manufactured by Bristol Myers Squibb, are beginning to approach the numbers of Xarelto sales. [read post]
